[go: up one dir, main page]

WO1988008711A1 - Substance pharmaceutique - Google Patents

Substance pharmaceutique Download PDF

Info

Publication number
WO1988008711A1
WO1988008711A1 PCT/DE1988/000283 DE8800283W WO8808711A1 WO 1988008711 A1 WO1988008711 A1 WO 1988008711A1 DE 8800283 W DE8800283 W DE 8800283W WO 8808711 A1 WO8808711 A1 WO 8808711A1
Authority
WO
WIPO (PCT)
Prior art keywords
family
radix
pharmaceutical
pharmaceutical according
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1988/000283
Other languages
German (de)
English (en)
Inventor
Vladimir Badmajew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO1988008711A1 publication Critical patent/WO1988008711A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)

Definitions

  • the invention relates to a pharmaceutical which is predominantly and preferably composed exclusively of comminuted plant components and minerals.
  • the invention is based on the object of specifying a pharmaceutical of the type mentioned at the outset which has improved therapeutic properties. is tolerated better and is particularly suitable for the therapy of abdominal inflammation, especially of women, for example premenstrual syndrome, ureter inflammation, kidney inflammation and other weaknesses of the immune system (antiseptic system) in the lower abdomen.
  • Trichosante radix in the form of an infusion or tea has antiseptic, anti-inflammatory and analgesic properties.
  • Trichosantes is used in the pharmaceutical preparation for the treatment of pelvic inflammation.
  • Pelvic inflammation is mainly caused by venereal diseases, such as infection with gonorrhea and chlamydia.
  • Pelvic inflammation is also one of the most common causes of infertility in women.
  • the active components of Trichosantes are known as Cucurbitacine, they are common to the family to which Trichosantes belongs, namely the Cucurbitaceae.
  • Tribulus radix has been used in pharmaceutical preparation to improve and support the antiseptic and anti-inflammatory properties of Trichosantes.
  • This ingredient also has diuretic properties.
  • the combination of diuretic and antiseptic properties makes this ingredient suitable in the pharmaceutical preparation for the treatment of urinary tract infections, which are a common complication in venereal diseases of women.
  • Polygonum herba has its application in the pharmaceutical according to the invention due to the diuretic (diuretic) coupled with anti-inflammatory, antipyretic and analgesic properties.
  • Taraxacum radix has similar therapeutic properties to Polygonum and is used in pharmaceuticals to support the biological effects of Polygonum.
  • the decisive effect and the therapeutic effect of the pharmaceutical are achieved by the special combination of its four components.
  • the pharmaceutical is recommended for the treatment of premenstrual syndromes, whereby this condition is characterized by three groups of symptoms:
  • the pharmaceutical according to the invention has proven particularly successful in combating and alleviating symptom groups 1 and 2.
  • An even more important application of the pharmaceutical according to the invention lies in the prevention of complications which can arise from venereal diseases, in particular infertility.
  • the current, modern therapy for venereal diseases uses antibiotics which, although they fight the infection, are not effective in treating inflammation which can influence and destroy the normal anatomical conditions in the reproductive apparatus of women.
  • the pharmaceutical according to the invention should be used in combination with antibiotic treatment for anti-inflammatory and antiseptic therapy.
  • the pharmaceutical is taken orally.
  • the active ingredients are available in high oophatic dosage.
  • the four constituents mentioned, Trichosantes palmata, Polygonum aviculare, Tribulus terrestris and Tara ⁇ xacum officinale (dandelion) are present in a weight ratio of 30: 30: 30: 10.
  • the completely dry plant constituents are crushed into powder and either compressed to tablets at a sufficiently high pressure or filled into a waterproof infusion bag, which e.g. is made from a filter paper.
  • the tablets do not have a coating or any other protective cover, they have sufficient mechanical stability due to their compression and, if necessary, the addition of a binder (such as gum arabic or PVP). They are therefore suitable, for example, for blister packs in which the tablet has to be pressed through an aluminum foil in order to access it.
  • a binder such as gum arabic or PVP
  • the tablet Since the tablet has no coating, one can experience the typical taste of the four plant components when ingested. As a result, the therapeutic effect begins in the mouth, the patient is consciously adjusted to the therapeutic effect by the taste of the pharmaceutical.
  • an herbal tea is brewed from the plant-based ingredients, which is consumed hot (or at least warm) (drunk).
  • one gram of the dry, powder-fine (grain size 0.025 to 0.035 mm) mixture is poured into a small infusion bag and sealed.
  • the contents of the bag are brewed (leached out) in boiling water, the cooking time (with gentle cooking) is determined either by means of a clock or by letting the amount of water used evaporate to 1/3.
  • a suitable vessel for example made of heat-resistant glass
  • two fill lines is advantageous, an upper fill line indicating the volume of 3 cups and the lower fill line indicating the volume of a cup.
  • Such a herbal tea can also be made from a tablet, leaving only a residue of brewed herbs in the container. This sentence is separated or filtered. The brew (herbal tea) is drunk warm or hot.
  • a Einrar ⁇ mtablette which is to be taken orally, or a corresponding infusion bag filling for the preparation of a tea has the following composition:

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Une substance pharmaceutique exclusivement composée d'éléments végétaux pulvérisés convient au traitement de douleurs du bas-ventre, en particulier chez des femmes, par exemple du syndrome pré-menstruel. Cette substances pharmaceutique se compose des éléments suivants, déshydratés et comprimés sous forme de poudre: Trichosantes palmata (radix), de la famille des cucurbitacées; Polygonum aviculare (herba), de la famille des polygonacées; Tribulus terrestris (radix), de la famille des zygophyles et Taraxacum officinale (radix), de la famille des composacées.
PCT/DE1988/000283 1987-05-14 1988-05-13 Substance pharmaceutique Ceased WO1988008711A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3716207.1 1987-05-14
DE3716207 1987-05-14

Publications (1)

Publication Number Publication Date
WO1988008711A1 true WO1988008711A1 (fr) 1988-11-17

Family

ID=6327577

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1988/000283 Ceased WO1988008711A1 (fr) 1987-05-14 1988-05-13 Substance pharmaceutique

Country Status (1)

Country Link
WO (1) WO1988008711A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021078349A1 (fr) 2019-10-23 2021-04-29 Portillo Rosado Rosa Maria Composition pharmaceutique obtenue à partir d'extraits de plantes pour le traitement de la fibromyalgie, de la polyarthrite rhumatoïde, du lupus et d'autres maladies auto-immunes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts, Band 97, Nr. 1, 5. Juli 1982, (Columbus, Ohio, US), M. Zhou et al.: "Pharmacological study of the effect of Radix Trichosanthis on terminating early pregnancy", siehe Seite 101 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021078349A1 (fr) 2019-10-23 2021-04-29 Portillo Rosado Rosa Maria Composition pharmaceutique obtenue à partir d'extraits de plantes pour le traitement de la fibromyalgie, de la polyarthrite rhumatoïde, du lupus et d'autres maladies auto-immunes

Similar Documents

Publication Publication Date Title
DE69830049T2 (de) Ätherisches öl beinhaltende zubereitung
CN103386022B (zh) 一种治疗结核性胸膜炎的中药组合物
CN105288041A (zh) 一种防治肾病综合征的中药制剂及制法
CN104873705A (zh) 一种治疗冠心病心绞痛的药物组合物及其应用
CN106806877A (zh) 改善痛经中药组合物及其制备方法和功能饮料
CN104857366A (zh) 一种神经外科术前干预药物组合物及其应用
WO1988008711A1 (fr) Substance pharmaceutique
CN115120690B (zh) 一种治疗性早熟的中药组合物及其应用
CN111617172A (zh) 一种外用中药组合物及其制备方法
CN107007784B (zh) 用于逆转Aβ淀粉样蛋白损伤神经细胞的中药组合物及其制备方法与应用
CN113521167B (zh) 一种治疗帕金森病的中药组合物及其应用
Elisha et al. An ethnobotanical survey of medicinal plants or preparations sold in markets of Zaria, Kaduna State, Nigeria
DE202007002146U1 (de) Neue Kräuterzusammensetzung
CN100413528C (zh) 一种治疗子宫内膜异位症的中药
CN112843204A (zh) 一种治疗甲状腺肿大的中药组合物及其制备方法和应用
CN114712446A (zh) 一种治疗胃病的中药组合物、制剂及其制备方法
CN104547803A (zh) 妇女产后高热清热祛毒中药组合物
CN105343688A (zh) 一种治疗心肌梗塞的药物组合物及其应用
CN104906345A (zh) 用于治疗稳定期慢性阻塞性肺疾病的中药组合物
CN119326836B (zh) 用于治疗或改善抑郁的中药制剂
CN103623109A (zh) 一种治疗缺血性脑血管病的中药组合物及其制备方法
CN113116973B (zh) 一种新的防治干燥综合症的中药复方及其制备方法、应用
CN110463799A (zh) 一种护肝通便茶的野生植物组合物
CN106620454A (zh) 一种治疗耐药性结核病的中药配方及其制备方法
KR100279214B1 (ko) 한약초를 이용한 항암제의 제조방법

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE